Zenith Drugs Set to Begin Production at New Facility by September 2025, Expanding Pharma Capabilities

Zenith Drugs Ltd. has announced that its new manufacturing facility in Indore, Madhya Pradesh is on track to commence full-scale production by September 30, 2025. The facility, which has been under construction since early 2024, will significantly expand the company’s production capacity, focusing on tablet and liquid oral formulations.

 

Facility Location & Expansion Plans:

Product Portfolio & Market Strategy:

Financial Growth & Investment:

Stock Market Reaction:

Following the announcement, Zenith Drugs’ stock jumped 11.1%, trading at ₹90 on NSE.

 

Future Outlook:

The company aims to ramp up production gradually, with full utilization expected by FY26.

Plans include introducing injectables, strengthening its presence in high-margin pharmaceutical segments.

 

Zenith Drugs’ new manufacturing facility marks a major milestone, reinforcing its commitment to innovation and market expansion.

 

Source:Economic Times, Trade Brains, and ValuePickr Forum.